Variation in uptake of sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor analogues in adults with type 2 diabetes at high cardiovascular risk. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.